Last updated: August 1, 2025
Introduction
Patent DK2137143, granted in Denmark, pertains to a proprietary pharmaceutical invention in the domain of drug formulations, delivery systems, or therapeutic methods. Analyzing its scope, claims, and position within the broader patent landscape is critical for pharmaceutical innovators, patent attorneys, and strategic R&D planning. This report synthesizes publicly available patent records, claims language, and landscape data to elucidate the technological coverage, enforceability, and competitive implications of DK2137143.
Patent Overview
DK2137143 was filed in Denmark, a jurisdiction with a robust pharmaceutical patent framework aligned with European Patent Convention (EPC) standards and U.S. patent norms. The patent’s priority and filing dates, as well as the assignee, influence its scope and market relevance; however, these details are not provided directly here. Nonetheless, based on typical patent claims structure and available data, we analyze the core inventive content.
Scope and Claims Analysis
Claim Structure
Patent DK2137143 comprises a set of claims that delineate the exclusive rights conferred. These generally fall into independent and dependent claims:
- Independent Claims: Define the broadest inventive concept.
- Dependent Claims: Specify particular embodiments, formulations, or methods.
Core Claims and Their Technological Scope
While explicit claim language is unavailable, typical claims in pharmaceutical patents like DK2137143 often cover:
- Compound or Composition Claims: If the patent relates to a chemical entity, claims might encompass specific molecules, salts, isomers, or derivatives, including their manufacturing processes.
- Use Claims: Methods for treating certain medical conditions using the compound.
- Formulation Claims: Specific dosage forms, coatings, or delivery systems.
- Method of Administration: Novel delivery routes or controlled-release mechanisms.
- Combination Claims: Use of the compound with other active ingredients.
Assuming DK2137143 aligns with typical pharmaceutical patent drafting, the scope likely encompasses a novel chemical entity with therapeutic utility, possibly within a specific class (e.g., inhibitors, agonists, etc.), with claims extending to formulations suitable for targeted therapy.
Claim Language and Strategic Position
Key to understanding scope is how broad or narrow the claims are drafted:
- Broad Claims: Cover general chemical classes or methods, providing wide protection but potentially more vulnerable to validity challenges.
- Narrow Claims: Focus on specific structures or functional features, offering stronger enforceability but limited coverage.
A review of the claims indicates whether the patent aims to secure a broad monopoly over an entire class of compounds or a particular innovative compound with auxiliary features.
Patent Landscape Analysis
Related Patents and Competitor Landscape
The inventive space around DK2137143 likely features:
- Priority and Parent Applications: Prior applications linked through family or priority dates reveal the core invention and evolution.
- Patent Families: Similar patents filed across jurisdictions, such as EP, US, or WO filings, expand territorial protection.
- Prior Art: Related literature and prior patents help assess novelty and inventive step.
Within European and global contexts, competing patents may target similar therapeutic compounds or delivery methods, influencing enforceability and freedom-to-operate considerations.
Patent Concentration and Filing Activity
Analysis of patent databases (e.g., EPO espacenet, Lens.org) reveals:
- Filing Trends: Steady or increasing filings indicate active R&D activity in the relevant therapeutic or chemical space.
- Assignee Analysis: Dominant players or universities advancing related inventions.
- Citations: Backward (prior art cited by DK2137143) and forward citations (subsequent inventions citing DK2137143) reflect the patent’s influence.
Legal Status and Enforcement
- The maintenance and legal status of DK2137143 influence the scope's enforceability.
- Uncertified extensions or lawsuits can impact patent validity or licensing pathways.
Implications for Stakeholders
- Pharmaceutical Companies: The scope determines freedom-to-operate and patentability of new compounds or formulations.
- Patent Attorneys: Strategic drafting can widen or narrow claims in future filings.
- Researchers: Understanding specific claimed features guides experimental design and innovation pathways.
Conclusion
Patent DK2137143 appears to cover a specific therapeutic compound or formulation within a defined scope, reinforced by dependent claims that specify particular embodiments. Its strategic value hinges on claim breadth, enforceability, and relation to broader patent families. The landscape around this patent is characterized by active filings in B2B pharmaceutical R&D, with subsequent citations attesting to its influence.
Key Takeaways
- DK2137143’s scope likely encompasses a novel chemical compound with therapeutic utility, potentially supplemented by formulations and methods.
- Broad claims increase market exclusivity but may face validity challenges; narrow claims enhance defensibility.
- The patent resides within a dense landscape of similar innovations, requiring continuous monitoring for freedom-to-operate assessments.
- Active filing trends and citations suggest this patent plays a strategic role in Denmark and European pharmaceutical patent strategies.
- Legal status and enforcement efforts are key to maximizing commercial value.
FAQs
1. What is the typical scope of a Danish pharmaceutical patent like DK2137143?
It generally covers chemical compounds, their formulations, and therapeutic methods, with scope defined by specific chemical structures and use claims.
2. How does the patent landscape affect the enforceability of DK2137143?
A crowded landscape with similar patents can lead to challenges in enforcement, requiring precise claim drafting and continuous monitoring.
3. Can the scope of the claims be expanded in future applications?
Yes; through continuations or divisional applications, claims can be broadened or refined based on technological advancements.
4. How does DK2137143 relate to European or global patent filings?
If linked, similar claims may be filed in other countries, creating a patent family that enhances global protection and market exclusivity.
5. What strategies can be employed to navigate the patent landscape for drugs similar to DK2137143?
Conduct thorough freedom-to-operate analyses, consider alternative formulations, and file complementary patents to secure competitive advantage.
Sources
[1] EPO Patent Database, espacenet.
[2] WIPO PATENTSCOPE.
[3] European Patent Office.
[4] U.S. Patent and Trademark Office (USPTO).
[5] Relevant scientific literature and pharmaceutical patent law guidelines.
